Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$597.6M
-70.2% from 2023
Prescriptions
1.9M
$312.39 per claim
Patients
588K
211,871 prescribers
Total spending, 2024
$597.8M
$1,016.65 per patient
Medicare prescription drug plans paid $597.6M for Symbicort in 2024, for 1,912,939 prescriptions and refills to 587,798 patients (down 70.2% from 2023). The average cost per claim was $312.39.
Florida had the highest Medicare cost for Symbicort in 2024: $57.1M for 181,959 claims, followed by Texas ($41.6M).
Jorge Sanchez-Masiques, pulmonary disease in Miami, FL, had the highest Medicare cost for Symbicort in 2024: 2,730 claims costing $644K.
Symbicort is made by AstraZeneca PLC (AZN), listed in the Medicare spending data as Astrazeneca.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jorge Sanchez-Masiques Miami, FL | Pulmonary Disease | 2,730 | 670 | $644K |
| Rafael A Martinez Tampa, FL | Pulmonary Disease | 1,095 | 302 | $289K |
| Matthew R Montoya |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 261,420 | 3,728,530 | 968,400 | $1.96B |
| 2023 | 269,122 | 3,727,414 | 983,896 | $2.00B |
| 2024 | 211,871 | 1,912,939 | 587,798 | $597.6M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pulmonary Disease |
| 802 |
| 153 |
| $236K |
| Dragos G Zanchi Brandon, FL | Pulmonary Disease | 817 | 228 | $229K |
| Jahaira L Serrano Dominguez Arecibo, PR | Pulmonary Disease | 903 | 256 | $215K |
| Andres A Redondo Miami, FL | Pulmonary Disease | 834 | 203 | $201K |
| Ppluis Echegaray Guaynabo, PR | Internal Medicine | 732 | 274 | $176K |
| Archie J Sanchez Albuquerque, NM | Pulmonary Disease | 559 | 119 | $170K |
| Vishnu A Patel Princeton, WV | Internal Medicine | 514 | 132 | $144K |
| Ernesto Mejia Morristown, TN | Pulmonary Disease | 461 | 103 | $142K |
| George W Bensch Stockton, CA | Allergy/ Immunology | 514 | 157 | $142K |
| Andrejs Belovs Lehigh Acres, FL | Physician Assistant | 264 | 81 | $137K |
| Jamie R Lujan Las Cruces, NM | Nurse Practitioner | 339 | 114 | $131K |
| Michael B Wert Greensboro, NC | Pulmonary Disease | 468 | 126 | $131K |
| Jesse Romeu-Velez Winter Haven, FL | Pulmonary Disease | 253 | 93 | $125K |
| George L Martin Wynnewood, PA | Allergy/ Immunology | 284 | 92 | $124K |
| Dima Adl Milwaukee, WI | Pulmonary Disease | 279 | 76 | $113K |
| Moses M Kitakule New Iberia, LA | Internal Medicine | 378 | 104 | $112K |
| Jason B Karp Lake Success, NY | Pulmonary Disease | 250 | 96 | $111K |
| Juan C Acevedo-Crespo Coral Gables, FL | Pulmonary Disease | 432 | 145 | $109K |
| Kevin J Twohig New Haven, CT | Pulmonary Disease | 295 | 99 | $107K |
| Carlos R Santos North Miami Beach, FL | Pulmonary Disease | 401 | 134 | $106K |
| Shahla G Naoman Batesville, AR | Pulmonary Disease | 368 | 84 | $104K |
| Ramakrishna Chakilam Corpus Christi, TX | Pulmonary Disease | 391 | 120 | $104K |
| David R Clark Morganton, NC | Pulmonary Disease | 370 | 107 | $100K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Astrazeneca AZN | 1,913,647 | $597.8M |